Immutep Limited
PRRUF
$0.04
-$0.01-21.11%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.98M | 1.97M | 604.40K | 591.80K | 1.03M |
| Total Other Revenue | -- | -- | 3.00K | 2.90K | -- |
| Total Revenue | 1.98M | 1.97M | 607.30K | 594.70K | 1.03M |
| Cost of Revenue | 15.30M | 15.25M | 11.56M | 11.32M | 8.25M |
| Gross Profit | -13.32M | -13.28M | -10.95M | -10.72M | -7.23M |
| SG&A Expenses | 1.78M | 1.78M | 1.41M | 1.38M | 1.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.08M | 17.03M | 12.97M | 12.70M | 9.63M |
| Operating Income | -15.10M | -15.06M | -12.36M | -12.11M | -8.61M |
| Income Before Tax | -14.72M | -14.68M | -12.51M | -12.25M | -7.29M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.72M | -14.68M | -12.51M | -12.25M | -7.29M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.72M | -14.68M | -12.51M | -12.25M | -7.29M |
| EBIT | -15.10M | -15.06M | -12.36M | -12.11M | -8.61M |
| EBITDA | -14.73M | -14.69M | -11.69M | -11.44M | -8.60M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 1.47B | 1.47B | 1.46B | 1.46B | 1.45B |
| Average Diluted Shares Outstanding | 1.47B | 1.47B | 1.46B | 1.46B | 1.45B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |